Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Preliminary effectiveness and safety in the first 88 patients with newly diagnosed locally advanced basal cell carcinoma treated with vismodegib in the RegiSONIC Disease Registry study Lacouture, M. E., Tang, J. Y., Rogers, G., Olencki, T., Kudchadkar, R. R., Yoo, S., Guillen, J., Mun, Y., Dawson, K., Sekulic, A. MOSBY-ELSEVIER. 2016: AB202
View details for Web of Science ID 000412760201672